跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial
Approved
STANDARD
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
63233be8d43839ce
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
63233be8d43839ce
Product Name
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial
Artg Id
126153
Artg Name
PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
2007-02-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01886-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-02114-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
63233be8d43839ce
Type
Standard
Back to TGA Approvals